cardiovascularКардиоваскулярная терапия и профилактикаCardiovascular Therapy and Prevention1728-88002619-0125«SILICEA-POLIGRAF» LLCcardiovascular-939Research ArticleОБЗОРЫ ЛИТЕРАТУРЫREVIEW ARTICLESАссоциация параметров психосоматического статуса и ремоделирования сердечно-сосудистой системы у больных артериальной гипертензиейPsychosomatic status parameters and cardiovascular remodeling in patients with arterial hypertensionШабалинА. В.ShabalinA. V.shabalin@online.nsk.suГуляеваЕ. Н.GulyaevaE. N.shabalin@online.nsk.suКоваленкоО. В.KovalenkoO. V.shabalin@online.nsk.suМышкинС. В.MyshkinS. V.shabalin@online.nsk.suВеркошанскаяЭ. М.VerkoshanskayaE. M.shabalin@online.nsk.suНовосибирская государственная медицинская академия, г. Новосибирск; НИИ терапии Сибирского отделения РАМН, г.НовосибирскNovosibirsk State Medical Academy, Institute of Internal Medicine, Siberian Branch, Russian Academy of Medical Sciences, NovosibirskКлиническая больница №1 ГУ Исполнения Наказаний Минюста России по Кемеровской области, г. КемеровоClinical Hospital №1, Kemerovo Region Central Administration for execution control, Ministry of Justice of the Russian Federation20052004200542108116Copyright © Шабалин А.В., Гуляева Е.Н., Коваленко О.В., Мышкин С.В., Веркошанская Э.М., 20052005Шабалин А.В., Гуляева Е.Н., Коваленко О.В., Мышкин С.В., Веркошанская Э.М.Shabalin A.V., Gulyaeva E.N., Kovalenko O.V., Myshkin S.V., Verkoshanskaya E.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://cardiovascular.elpub.ru/jour/article/view/939

Обзор посвящен роли факторов психосоматического статуса людей в развитии патологического сердечно-сосудистого ремоделирования при эссенциальной артериальной гипертензии. Подробно рассмотрены клеточные механизмы гипертрофии левого желудочка, а также влияние факторов риска сердечнососудистых заболеваний на ее прогрессирование.

The review is devoted to the role of psychosomatic status factors in the development of pathological cardiovascular remodeling in essential arterial hypertension. Cell mechanisms of left ventricular hypertrophy, cardiovascular risk factors’ influence on its progression are analyzed in detail.

эссенциальная артериальная гипертензияфакторы рискасердечно-сосудистое ремоделированиеessential arterial hypertensionrisk factorscardiovascular remodelingReferencesБелова Е.В. Участие гипоталамо-гипофизарно-надпочечниковой системы в повышении АД под воздействием эмоциональной нагрузки при артериальной гипертензии. Кардиология 1993; 3: 37-9.Белова Е.В. Участие гипоталамо-гипофизарно-надпочечниковой системы в повышении АД под воздействием эмоциональной нагрузки при артериальной гипертензии. Кардиология 1993; 3: 37-9.Гогин Е.Е. Гипертоническая болезнь. Москва 1997.Гогин Е.Е. Гипертоническая болезнь. Москва 1997.Горнаев Б.И., Дорничев В.М. Реакция системы кровообращения при психоэмоциональном напряжении. Кровообращение 1986; 5: 7-11.Горнаев Б.И., Дорничев В.М. Реакция системы кровообращения при психоэмоциональном напряжении. Кровообращение 1986; 5: 7-11.Грачев А.В., Аляви А.Л., Рузметова И.А. и др. 24-часовое мониторирование артериального давления, дозированная изометрическая и динамическая физические нагрузки, внутрисердечная гемодинамика и ремоделирование сердца у больных эссенциальной артериальной гипертензией. Вест аритмол 2000; 19: 6-16.Грачев А.В., Аляви А.Л., Рузметова И.А. и др. 24-часовое мониторирование артериального давления, дозированная изометрическая и динамическая физические нагрузки, внутрисердечная гемодинамика и ремоделирование сердца у больных эссенциальной артериальной гипертензией. Вест аритмол 2000; 19: 6-16.Грачев А.В., Аляви А.Л., Ниязова Г.У. и др. Масса миокарда левого желудочка, его функциональное состояние и диастолическая функция сердца у больных артериальной гипертонией при различных эхокардиографических типах геометрии левого желудочка сердца. Кардиология 2000; З: 31-8.Грачев А.В., Аляви А.Л., Ниязова Г.У. и др. Масса миокарда левого желудочка, его функциональное состояние и диастолическая функция сердца у больных артериальной гипертонией при различных эхокардиографических типах геометрии левого желудочка сердца. Кардиология 2000; З: 31-8.Дроздова Г.А. Клеточные механизмы артериальной гипертензии. Пат физиол эксперим тер 2000; 2: 26-30.Дроздова Г.А. Клеточные механизмы артериальной гипертензии. Пат физиол эксперим тер 2000; 2: 26-30.Карпов Р.С., Пузырев К.В., Павлюкова Е.Н. и др. Молекулярно-генетический анализ гипертрофии миокарда левого желудочка. Кардиология 2001; 6: 25-30.Карпов Р.С., Пузырев К.В., Павлюкова Е.Н. и др. Молекулярно-генетический анализ гипертрофии миокарда левого желудочка. Кардиология 2001; 6: 25-30.Кобалава Ж.Д., Котовская Ю.В., Чистяков Д.А. и др. Клинико-генетические детерминанты гипертрофии левого желудочка у больных эссенциальной гипертонией. Кардиология 2001; 7: 39-44.Кобалава Ж.Д., Котовская Ю.В., Чистяков Д.А. и др. Клинико-генетические детерминанты гипертрофии левого желудочка у больных эссенциальной гипертонией. Кардиология 2001; 7: 39-44.Кузьмин А.И., Фоменко Г.В., Медведев О.С. и др. Гемодинамические и нейрогумфальные реакции, вызванные субмаксимальными динамической и изометрической нагрузками у больных гипертонической болезнью. Бюлл ВКНЦ АМН СССР 1989; 2: 42-6.Кузьмин А.И., Фоменко Г.В., Медведев О.С. и др. Гемодинамические и нейрогумфальные реакции, вызванные субмаксимальными динамической и изометрической нагрузками у больных гипертонической болезнью. Бюлл ВКНЦ АМН СССР 1989; 2: 42-6.Мартынов А.И., Степура О.Б., Иванова С.В. и др. Ремоделирование и диастолическая функция левого желудочка сердца у больных с артериальной гипертензией (по материалам XVII-XXI конгрессов Европейского общества кардиологов). Кардиология 2001; 7: 67-70.Мартынов А.И., Степура О.Б., Иванова С.В. и др. Ремоделирование и диастолическая функция левого желудочка сердца у больных с артериальной гипертензией (по материалам XVII-XXI конгрессов Европейского общества кардиологов). Кардиология 2001; 7: 67-70.Минушина Л.О., Затейщикова А.А., Хотченкова Н.В. и др. Активность ренин-альдостероновой системы и особенности структуры и функции миокарда левого желудочка у больных артериальной гипертензией. Кардиология 2000; 9: 23-7.Минушина Л.О., Затейщикова А.А., Хотченкова Н.В. и др. Активность ренин-альдостероновой системы и особенности структуры и функции миокарда левого желудочка у больных артериальной гипертензией. Кардиология 2000; 9: 23-7.Никитин Ю.П., Малютина С.К., Долгих М.М. и др. Гипертрофия левого желудочка: популяционное и молекулярногенетическое исследование. Кардиология 1999; 6: 27-30.Никитин Ю.П., Малютина С.К., Долгих М.М. и др. Гипертрофия левого желудочка: популяционное и молекулярногенетическое исследование. Кардиология 1999; 6: 27-30.Парфенов Е.В., Красникова Т.Л., Арипова Н.А. и др. Состояние бета 2-адренорецепторной системы лимфоцитов у больных гипертонической болезнью левого желудочка различной степени. Кардиология 1991; 12: 33-5.Парфенов Е.В., Красникова Т.Л., Арипова Н.А. и др. Состояние бета 2-адренорецепторной системы лимфоцитов у больных гипертонической болезнью левого желудочка различной степени. Кардиология 1991; 12: 33-5.Пузырев В.П. Генетика артериальной гипертензии (современные исследовательские парадигмы). Клин мед 2003; 1: 12-8.Пузырев В.П. Генетика артериальной гипертензии (современные исследовательские парадигмы). Клин мед 2003; 1: 12-8.Рязанов А.С., Аракелянц А.А., Юренев А.П. Гипертоническое сердце. Состояние проблемы. Клин мед 2003; 6: 15-8.Рязанов А.С., Аракелянц А.А., Юренев А.П. Гипертоническое сердце. Состояние проблемы. Клин мед 2003; 6: 15-8.Терентьев В.П., Беловолова Е.В., Зонис Б.Я. Особенности функционирования симпато-адреналовой системы у больных артериальной гипертензией с различными вариантами ремоделирования левого желудочка при его гипертрофии. РКЖ. 2001; 4: 39-42.Терентьев В.П., Беловолова Е.В., Зонис Б.Я. Особенности функционирования симпато-адреналовой системы у больных артериальной гипертензией с различными вариантами ремоделирования левого желудочка при его гипертрофии. РКЖ. 2001; 4: 39-42.Тигранян Р.А. Гормонально-метаболический статус организма при экстремальных воздействиях. Москва 1990; 286.Тигранян Р.А. Гормонально-метаболический статус организма при экстремальных воздействиях. Москва 1990; 286.Туев А.В., Ховаева Я.Б. Особенности структурно-функциональных показателей сердца у лиц с разным уровнем артериального давления. РКЖ 2002; 5: 38-41.Туев А.В., Ховаева Я.Б. Особенности структурно-функциональных показателей сердца у лиц с разным уровнем артериального давления. РКЖ 2002; 5: 38-41.Флоря В.Г. Роль ремоделирования левого желудочка в патогенезе хронической недостаточности кровообращения. Кардиология 1997; 5: 63-70.Флоря В.Г. Роль ремоделирования левого желудочка в патогенезе хронической недостаточности кровообращения. Кардиология 1997; 5: 63-70.Шулутко Б.И. Артериальная гипертензия. Санкт-Петербург 2001: 382. 21. Aeschbacher BC, Hutter D, Fuhrer J, et al. Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Am J Hypertens 2001; 4(2): 106-13.Шулутко Б.И. Артериальная гипертензия. Санкт-Петербург 2001: 382. 21. Aeschbacher BC, Hutter D, Fuhrer J, et al. Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Am J Hypertens 2001; 4(2): 106-13.Akers WS, Cross A, Speth R, et al. Renin-angiotensin system and sympathetic nervous system in cardiac pressure-overload hypertrophy. Am J Physiol Heart Circ Physio 2000; 279(6): 2797-806.Akers WS, Cross A, Speth R, et al. Renin-angiotensin system and sympathetic nervous system in cardiac pressure-overload hypertrophy. Am J Physiol Heart Circ Physio 2000; 279(6): 2797-806.Armario P, Hernandez del Rey R, Torres G, et al. Relationship in cardiovascular reactivity to mental stress and early involvement of target organs in non- treated mild arterial hypertension. Hospitalet Study. Med Clin 1999; 113(11): 401-16.Armario P, Hernandez del Rey R, Torres G, et al. Relationship in cardiovascular reactivity to mental stress and early involvement of target organs in non- treated mild arterial hypertension. Hospitalet Study. Med Clin 1999; 113(11): 401-16.Аl’Absi M, Devereux RB, Lewis CE, et al. Blood pressure responses to acute stress and left ventricular mass. Am J Cardiol 2002; 89(5): 536-40.Аl’Absi M, Devereux RB, Lewis CE, et al. Blood pressure responses to acute stress and left ventricular mass. Am J Cardiol 2002; 89(5): 536-40.Aurigemma GP, Devereux RB, De Simone G, et al. Myocardial function and geometry in hypertensive subjects with low levels of afterload. Am Heart J 2002; 143(3): 546-51.Aurigemma GP, Devereux RB, De Simone G, et al. Myocardial function and geometry in hypertensive subjects with low levels of afterload. Am Heart J 2002; 143(3): 546-51.Aguirre-Ramos R, Trujillo-Hernandez B, Huerta M, et al. White-coat hyper tension and risk factors in recently diag nosed hypertensive Patients. Gac Med 2002; 138(4): 319-24.Aguirre-Ramos R, Trujillo-Hernandez B, Huerta M, et al. White-coat hyper tension and risk factors in recently diag nosed hypertensive Patients. Gac Med 2002; 138(4): 319-24.Bautista LE, Vera-Cala LM, Villamil LT, et al. Risk factors associated with the prevalence of arterial hypertension in adults in Bucaramanga, Colombia. Salud Publica Mex 2002; 44(5): 399-405.Bautista LE, Vera-Cala LM, Villamil LT, et al. Risk factors associated with the prevalence of arterial hypertension in adults in Bucaramanga, Colombia. Salud Publica Mex 2002; 44(5): 399-405.Bell D, Allen AR, Kelso EJ, et al. Induction of hypertrophic sponsiveness of cardiomyocytes to neuropeptide Y in response to pressure overload. J Pharmacol Exp Ther 2002; 303(2): 581-91.Bell D, Allen AR, Kelso EJ, et al. Induction of hypertrophic sponsiveness of cardiomyocytes to neuropeptide Y in response to pressure overload. J Pharmacol Exp Ther 2002; 303(2): 581-91.Beretta-Picoli C, Pusterlac, Stadley P, et al. Blunted aldosterone responsiveness to anqiotensin II in normotensive subjects with familial predisposition to essential hypertension. J Hypertens 1988; 6: 57-61.Beretta-Picoli C, Pusterlac, Stadley P, et al. Blunted aldosterone responsiveness to anqiotensin II in normotensive subjects with familial predisposition to essential hypertension. J Hypertens 1988; 6: 57-61.Berger R, Paran E. Stress and hypertension. Harefuah 2002; 141(7): 626-65.Berger R, Paran E. Stress and hypertension. Harefuah 2002; 141(7): 626-65.Bjorklund K, Lind L, Vessby B, et al. Different metabolic predictors of white- coat and sustained hypertension over a 20-year follow-up period: a population-based study of elderly men. Circulation 2002; 106(1): 63-8.Bjorklund K, Lind L, Vessby B, et al. Different metabolic predictors of white- coat and sustained hypertension over a 20-year follow-up period: a population-based study of elderly men. Circulation 2002; 106(1): 63-8.Bohlender J, Hildenbrand U, Wagner KD, et al. Myocardial adrenergic dysfunction in rats with transgenic, human renin-dependent hypertension. J Hypertens 2001; 19(8): 1453-63.Bohlender J, Hildenbrand U, Wagner KD, et al. Myocardial adrenergic dysfunction in rats with transgenic, human renin-dependent hypertension. J Hypertens 2001; 19(8): 1453-63.Boon NA, Elliot JM, Davies CL, et al. Platelet alpha – adrenoceptors in borderline and established essential hypertension. Clin Sci 1983; 65: 265-72.Boon NA, Elliot JM, Davies CL, et al. Platelet alpha – adrenoceptors in borderline and established essential hypertension. Clin Sci 1983; 65: 265-72.Calls J, Cases A, Lario S, et al. Beta-adrenergic receptor density and function in left ventricular hypertrophy in young essential hypertensives. J Hum Hypertens 2000; 14(1): 17-21.Calls J, Cases A, Lario S, et al. Beta-adrenergic receptor density and function in left ventricular hypertrophy in young essential hypertensives. J Hum Hypertens 2000; 14(1): 17-21.Lacour C, Consoli SM. Psychological and behavior characteristics predicting blood pressure reactivity to mental stress. Arch Mal Coeur Vaiss 1993; 86(8): 1177-80.Lacour C, Consoli SM. Psychological and behavior characteristics predicting blood pressure reactivity to mental stress. Arch Mal Coeur Vaiss 1993; 86(8): 1177-80.Carretero OA, Scicli AG. Text book of Hypertension. Oxford 1994; 328-40.Carretero OA, Scicli AG. Text book of Hypertension. Oxford 1994; 328-40.Collins R, Winkleby M.A. African American women and men at high and low risk for hypertension: a signal detection analysis of NHANES III, 1988-1994. Prev Med 2002; 35(4): 303-12.Collins R, Winkleby M.A. African American women and men at high and low risk for hypertension: a signal detection analysis of NHANES III, 1988-1994. Prev Med 2002; 35(4): 303-12.Fagard RH, Van Den Enden M, Leeman M, et al. Survey on treatment of pertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium. J Hypertens 2002; 20(7): 1297-302.Fagard RH, Van Den Enden M, Leeman M, et al. Survey on treatment of pertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium. J Hypertens 2002; 20(7): 1297-302.Dang A, Zheng D, Wang B, et al. The role of the rennin-angiotensin and cardiac sympathetic nervous systems in the development of hypertension and left ventricular hypertrophy in spontaneously hypertensive rats. Hypertens Res 1999; 22(3): 217-21.Dang A, Zheng D, Wang B, et al. The role of the rennin-angiotensin and cardiac sympathetic nervous systems in the development of hypertension and left ventricular hypertrophy in spontaneously hypertensive rats. Hypertens Res 1999; 22(3): 217-21.Dekkers JC, Snieder H, Van Den Oord EJ, et al. Moderators of blood pressure development from childhood to adulthood: a 10- year longitudinal study. J Pediatr 2002; 141(6): 770-9.Dekkers JC, Snieder H, Van Den Oord EJ, et al. Moderators of blood pressure development from childhood to adulthood: a 10- year longitudinal study. J Pediatr 2002; 141(6): 770-9.Derhaschnig U, Shehata M, Herkner H, et al. Increased levels of ransforming growth factor-beta1 in essential hypertension. Am J Hypertens 2002; 15(3): 207-11.Derhaschnig U, Shehata M, Herkner H, et al. Increased levels of ransforming growth factor-beta1 in essential hypertension. Am J Hypertens 2002; 15(3): 207-11.Devereux RB, Roman MJ. Left ventricular hypertrophy: stimuli, patterns and consequences. Hypertens Res 1999; 22(1): 1-9.Devereux RB, Roman MJ. Left ventricular hypertrophy: stimuli, patterns and consequences. Hypertens Res 1999; 22(1): 1-9.Devereux RB, Pickering TG, Harshfield GA, et al. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly stress. Circulation 1983; 68: 470-6.Devereux RB, Pickering TG, Harshfield GA, et al. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly stress. Circulation 1983; 68: 470-6.De las Fuentes L, Herrero P, Peterson L, et al. Myocardial fatty acid metabolism: independent predictor of left ventricular mass in hypertensive heart disease. Hypertension 2003; 41(1): 83-7.De las Fuentes L, Herrero P, Peterson L, et al. Myocardial fatty acid metabolism: independent predictor of left ventricular mass in hypertensive heart disease. Hypertension 2003; 41(1): 83-7.De Wardener HE, MacGregor GA. Sodium and blood pressure. Curr Opin Cardiol 2002; 17(4): 360-7.De Wardener HE, MacGregor GA. Sodium and blood pressure. Curr Opin Cardiol 2002; 17(4): 360-7.Diez J, Querejeta R, Lopez B, et al. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002; 105(21): 2512-7.Diez J, Querejeta R, Lopez B, et al. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002; 105(21): 2512-7.Fauvel JP. Cardiovascular impact of psychological stress. Ann Cardiol Angeiol 2002; 51(2): 76-80.Fauvel JP. Cardiovascular impact of psychological stress. Ann Cardiol Angeiol 2002; 51(2): 76-80.Franz HM. Hypertension and sudden cardiac death. Am J Hypertens 1999; 12(12): 181-7.Franz HM. Hypertension and sudden cardiac death. Am J Hypertens 1999; 12(12): 181-7.Foucan L, Hanley J, Deloumeaux J, et al. Body mass index (BMI) and waist circumference (WC) as screening tools for cardiovascular risk factors in Guadeloupean women. J Clin Epidemiol 2002; 55(10): 990-6.Foucan L, Hanley J, Deloumeaux J, et al. Body mass index (BMI) and waist circumference (WC) as screening tools for cardiovascular risk factors in Guadeloupean women. J Clin Epidemiol 2002; 55(10): 990-6.Galderisi M, Cicala S, De Simone L, et al. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy. Ital Heart J 2001; 2(9): 677-84.Galderisi M, Cicala S, De Simone L, et al. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy. Ital Heart J 2001; 2(9): 677-84.Galderisi M, Cicala S, Caso P, et al. Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension. Am J Cardiol 2002; 90(8): 860-4.Galderisi M, Cicala S, Caso P, et al. Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension. Am J Cardiol 2002; 90(8): 860-4.Galipeau DM, Yao L, McNeill J. H. Relationship among hyperinsulinemia, insulin resistance, and hypertension is dependent on sex. Am J Physiol Heart Circ Physiol 2002; 283(2): 562-7.Galipeau DM, Yao L, McNeill J. H. Relationship among hyperinsulinemia, insulin resistance, and hypertension is dependent on sex. Am J Physiol Heart Circ Physiol 2002; 283(2): 562-7.Gianaros PJ, Bleil ME, Muldoon MF, et al. Is cardiovascular reactivity associated with atherosclerosis among hypertensives? Hypertension 2002; 40(5): 742-7.Gianaros PJ, Bleil ME, Muldoon MF, et al. Is cardiovascular reactivity associated with atherosclerosis among hypertensives? Hypertension 2002; 40(5): 742-7.Gonzalez A, Lopez B, Ravassa S, et al. Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II. Hypertension 2002; 39(1): 75-80.Gonzalez A, Lopez B, Ravassa S, et al. Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II. Hypertension 2002; 39(1): 75-80.Greenwood JP, Scott EM, Stoker J, et al. Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive. JACC 2001; 38(6): 1711-7.Greenwood JP, Scott EM, Stoker J, et al. Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive. JACC 2001; 38(6): 1711-7.Henriksson KM, Lindblad U, Gullberg B, et al. Development of hypertension over 6 years in a birth cohort of young middle-aged men: the Cardiovascular Risk Factor Study in southern Sweden (CRISS). J Intern Med 2002; 252(1): 21-6.Henriksson KM, Lindblad U, Gullberg B, et al. Development of hypertension over 6 years in a birth cohort of young middle-aged men: the Cardiovascular Risk Factor Study in southern Sweden (CRISS). J Intern Med 2002; 252(1): 21-6.Kamide K, Rakugi H, Higaki J, et al. The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats. Am J Hypertens 2002; 15(1): 66-71.Kamide K, Rakugi H, Higaki J, et al. The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats. Am J Hypertens 2002; 15(1): 66-71.Kanezik R, Michel MC, Khamssi M, et al. Alfa – and beta – adrenozeptoren bei Hypertonie: Kardiale and renale Adrenzeptoren in tiermodellen der erworbenen Hypertonie (Abstract). Hochdruck 1987; 7: 40-2.Kanezik R, Michel MC, Khamssi M, et al. Alfa – and beta – adrenozeptoren bei Hypertonie: Kardiale and renale Adrenzeptoren in tiermodellen der erworbenen Hypertonie (Abstract). Hochdruck 1987; 7: 40-2.Kuwahara T, Hamada M, Hiwada K. Direct evidence of impaired cardiac sympathetic innervation in essential hypertensive patients with left ventricular hypertrophy. J Nucl Med 1998; 39(9): 1486-91.Kuwahara T, Hamada M, Hiwada K. Direct evidence of impaired cardiac sympathetic innervation in essential hypertensive patients with left ventricular hypertrophy. J Nucl Med 1998; 39(9): 1486-91.Kuwahara F, Kai H, Tokuda K, et al. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 2002; 106(1): 130-5.Kuwahara F, Kai H, Tokuda K, et al. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 2002; 106(1): 130-5.Krzesinski JM. Epidemiology of arterial hypertension. Rev Med Liege 2002; 57(3): 142-7.Krzesinski JM. Epidemiology of arterial hypertension. Rev Med Liege 2002; 57(3): 142-7.Lantelme P, Custaud MA, Vincent M, et al. Clinical implications of blood pressure variability. Arch Mal Coeur Vaiss 2002; 95(9): 787-92.Lantelme P, Custaud MA, Vincent M, et al. Clinical implications of blood pressure variability. Arch Mal Coeur Vaiss 2002; 95(9): 787-92.Li W, Sun N, Liu W, et al. Influence of Valsartan on myocardial apoptosis in spontaneously hypertensive rats. Chin Med J 2002; 115(3): 364-6.Li W, Sun N, Liu W, et al. Influence of Valsartan on myocardial apoptosis in spontaneously hypertensive rats. Chin Med J 2002; 115(3): 364-6.Lindsay MM, Maxwell P, Dunn FG. TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension. Hypertension 2002; 40(2): 36-41.Lindsay MM, Maxwell P, Dunn FG. TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension. Hypertension 2002; 40(2): 36-41.Leenen FH, Yuan B. Dietary-sodium-induced cardiac remodeling in spontaneously hypertensive rat versus Wistar-Kyoto rat. J Hypertens 1998; 6(6): 885-92.Leenen FH, Yuan B. Dietary-sodium-induced cardiac remodeling in spontaneously hypertensive rat versus Wistar-Kyoto rat. J Hypertens 1998; 6(6): 885-92.Lim PO, Donnan PT, MacDonald TM. Aldosterone to renin ratio as a determinant of exercise blood pressure response in hypertensive patients. J Hum Hypertens 2001; 15(2): 119-23.Lim PO, Donnan PT, MacDonald TM. Aldosterone to renin ratio as a determinant of exercise blood pressure response in hypertensive patients. J Hum Hypertens 2001; 15(2): 119-23.Lim PO, Donnan PT, MacDonald TM. Blood pressure determinants of left ventricular wall thickness and mass index in hypertension: comparing office, ambulatory and exercise blood pressures. J Hum Hypertens 2001; 15(9): 627-33.Lim PO, Donnan PT, MacDonald TM. Blood pressure determinants of left ventricular wall thickness and mass index in hypertension: comparing office, ambulatory and exercise blood pressures. J Hum Hypertens 2001; 15(9): 627-33.Mann SJ, Gerber LM. Psychological characteristics and responses to antihyper-tensive drug therapy. J Clin Hypertens 2002; 4(1): 25-34.Mann SJ, Gerber LM. Psychological characteristics and responses to antihyper-tensive drug therapy. J Clin Hypertens 2002; 4(1): 25-34.Manolis A, Athanasopoulos G, Karatasakis G, et al. Pressor hormone profile during stress in hypertension: does vasopressin interfere with left ventricular hypertrophy? Clin Exp Hypertens 1993; 15(3): 539-55.Manolis A, Athanasopoulos G, Karatasakis G, et al. Pressor hormone profile during stress in hypertension: does vasopressin interfere with left ventricular hypertrophy? Clin Exp Hypertens 1993; 15(3): 539-55.Montani JP, Antic V, Yang Z, et al. Pathways from obesity to hypertension: from the perspective of a vicious triangle. Int J Obes Relat Metab Disord 2002; 26(2): 28-38.Montani JP, Antic V, Yang Z, et al. Pathways from obesity to hypertension: from the perspective of a vicious triangle. Int J Obes Relat Metab Disord 2002; 26(2): 28-38.Murphy R. Textbook of Hypertension. Oxford 1994; 139-45.Murphy R. Textbook of Hypertension. Oxford 1994; 139-45.Nair VM, Tekin UN, Khan IA. Worsening of left ventricular diastolic dysfunction during exercise causes decreased exercise tolerance in hypertension. Clin Cardiol 2000; 23(9): 660-4.Nair VM, Tekin UN, Khan IA. Worsening of left ventricular diastolic dysfunction during exercise causes decreased exercise tolerance in hypertension. Clin Cardiol 2000; 23(9): 660-4.Nirmala A. Age variation in blood pressure: effect of sex and urbanization in a genetically homogeneous caste population of Andhra Pradesh. Am J Human Biol 2001; 13(6): 744-52.Nirmala A. Age variation in blood pressure: effect of sex and urbanization in a genetically homogeneous caste population of Andhra Pradesh. Am J Human Biol 2001; 13(6): 744-52.Nystron F, Aardal E, Ohman KP. A population – based study of the white- coat blood pressure effect: positive correlation with plasma cortisol. Clin Exp Hypertens 1998; 20(1): 95-104.Nystron F, Aardal E, Ohman KP. A population – based study of the white- coat blood pressure effect: positive correlation with plasma cortisol. Clin Exp Hypertens 1998; 20(1): 95-104.Pausehinger M, Lentz S, Dorner A, et al. Gene expression of collagen type I and type III in SHR (Abstract). Eur Heart J 1994; 15: 566.Pausehinger M, Lentz S, Dorner A, et al. Gene expression of collagen type I and type III in SHR (Abstract). Eur Heart J 1994; 15: 566.Paolisso G, Tagliamonte MR, Galderisi M, et al. Plasma leptin concentration, insulin sensitivity, and 24-hour ambulatory blood pressure and left ventricular geometry. Am J Hypertens 2001; 14(2): 114-20.Paolisso G, Tagliamonte MR, Galderisi M, et al. Plasma leptin concentration, insulin sensitivity, and 24-hour ambulatory blood pressure and left ventricular geometry. Am J Hypertens 2001; 14(2): 114-20.Piuhola J, Szokodi I, Kinnunen P, et al. Endothelin-1 contributes to the Frank-Starling response in hypertrophic rat hearts. Hypertension 2003; 41(1): 93-8.Piuhola J, Szokodi I, Kinnunen P, et al. Endothelin-1 contributes to the Frank-Starling response in hypertrophic rat hearts. Hypertension 2003; 41(1): 93-8.Pruszczyk P, Chlebus M. Plasma neuropeptide Y during dynamic exercise in patients with essential hypertension. Clin Exp Hypertens 1995; 17(5): 769-85.Pruszczyk P, Chlebus M. Plasma neuropeptide Y during dynamic exercise in patients with essential hypertension. Clin Exp Hypertens 1995; 17(5): 769-85.Quilley J, Mc Giff JC. Textbook of Hypertension. Oxford 1994; 314-27.Quilley J, Mc Giff JC. Textbook of Hypertension. Oxford 1994; 314-27.Ragoobirsingh D, McGrowder D, Morrison EY, et al. The Jamaican hypertension prevalence study. J Natl Med Assoc 2002; 94(7): 561-5.Ragoobirsingh D, McGrowder D, Morrison EY, et al. The Jamaican hypertension prevalence study. J Natl Med Assoc 2002; 94(7): 561-5.Richard BD, Giovanni de S, Jhomas GP, et al. Relation of left ventricular midwall function to cardiovascular risk factors and arterial structure and function. Hypertension 1998; 31: 929-36.Richard BD, Giovanni de S, Jhomas GP, et al. Relation of left ventricular midwall function to cardiovascular risk factors and arterial structure and function. Hypertension 1998; 31: 929-36.Rutledge T, Hogan BE. A quantitative review of prospective evidence linking psychological factors with hypertension development. Psychosom Med 2002; 64(5): 758-66.Rutledge T, Hogan BE. A quantitative review of prospective evidence linking psychological factors with hypertension development. Psychosom Med 2002; 64(5): 758-66.Sanchez A, Vidal MJ, Martinez-Sierra R, et al. Ontodeny of renal alpha - 1 and alpha – 2 adrenoceptors in the spontaneously hypertensive rat. J Pharmacol Exp Ther 1986; 237: 972-9.Sanchez A, Vidal MJ, Martinez-Sierra R, et al. Ontodeny of renal alpha - 1 and alpha – 2 adrenoceptors in the spontaneously hypertensive rat. J Pharmacol Exp Ther 1986; 237: 972-9.Schnall PL, Pieper C, Schwartz JE, et al. The relationship between job strain, workplace, diastolic blood pressure, and left ventricular mass index. JAMA 1990; 263: 1929-35.Schnall PL, Pieper C, Schwartz JE, et al. The relationship between job strain, workplace, diastolic blood pressure, and left ventricular mass index. JAMA 1990; 263: 1929-35.Schnall PL, Schwarz JE, Landsbergis PA, et al. Relation between job strain, alcohol and ambulatory blood pressure. Hypertension 1992; 19: 488-94.Schnall PL, Schwarz JE, Landsbergis PA, et al. Relation between job strain, alcohol and ambulatory blood pressure. Hypertension 1992; 19: 488-94.Schwartz GL, Strong CG. Renal parenchymal involvement in essential hypertension. Medical clinics of North America 1987; 71: 843-58.Schwartz GL, Strong CG. Renal parenchymal involvement in essential hypertension. Medical clinics of North America 1987; 71: 843-58.Schroder H, Schmelz E, Marrugat J. Relationship between diet and blood pressure in a representative Mediterranean population. Eur J Nutr 2002; 40(4): 161-7.Schroder H, Schmelz E, Marrugat J. Relationship between diet and blood pressure in a representative Mediterranean population. Eur J Nutr 2002; 40(4): 161-7.Sherwood A, Gullette EC, Hinderliter AL, et al. Relationship of clinic, ambulatory, and laboratory stress blood pressure to left ventricular mass in overweight men and women with high blood pressure. Psychosom Med 2002; 64(2): 247-57.Sherwood A, Gullette EC, Hinderliter AL, et al. Relationship of clinic, ambulatory, and laboratory stress blood pressure to left ventricular mass in overweight men and women with high blood pressure. Psychosom Med 2002; 64(2): 247-57.Sorof J, Daniels S. Obesity hypertension in children: a problem of epidemic Proportions. Hypertension 2002; 40(4): 441-7.Sorof J, Daniels S. Obesity hypertension in children: a problem of epidemic Proportions. Hypertension 2002; 40(4): 441-7.Tabeta I, Ueshiba H, Ichijo T, et al. Comment: the corticotropinreleasing hormone stimulation test in white coat hypertension. J Clin Endocrinol Metab 2002; 87(8): 3672-5.Tabeta I, Ueshiba H, Ichijo T, et al. Comment: the corticotropinreleasing hormone stimulation test in white coat hypertension. J Clin Endocrinol Metab 2002; 87(8): 3672-5.Tiago AD, Samani NJ, Candy GP, et al. Angiotensinogen gene promoter region variant modifies body size-ambulatory blood pressure relations in hypertension. Circulation 2002; 106(12): 1483-7.Tiago AD, Samani NJ, Candy GP, et al. Angiotensinogen gene promoter region variant modifies body size-ambulatory blood pressure relations in hypertension. Circulation 2002; 106(12): 1483-7.Jiang Y, Qu P, Ding Y. The relation between left ventricular geometric patterns and left ventricular midwall mechanics in hypertensive patients. Hypertens 2002; 25(2): 191-5.Jiang Y, Qu P, Ding Y. The relation between left ventricular geometric patterns and left ventricular midwall mechanics in hypertensive patients. Hypertens 2002; 25(2): 191-5.Tsai PS. White coat hypertension: understanding the concept and examining the significance. J Clin Nurs 2002; 11(6): 715-22.Tsai PS. White coat hypertension: understanding the concept and examining the significance. J Clin Nurs 2002; 11(6): 715-22.Vasan RS, Larson MG, Leip EP, et al. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358(9294): 1682-6.Vasan RS, Larson MG, Leip EP, et al. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358(9294): 1682-6.Yamamoto K, Masuyama T, Sakata Y, et al. Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart. Cardiovasc Res 2002; 55(1): 76-82.Yamamoto K, Masuyama T, Sakata Y, et al. Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart. Cardiovasc Res 2002; 55(1): 76-82.Zhan S, Liu M, Yao W, et al. Prevalence and relevant factors on echocardiographic left ventricular hypertrophy among community-based hypertensive patients in Shanghai. Zhonghua Liu Xing Bing Xue Za Zh 2002; 23(3): 182-5.Zhan S, Liu M, Yao W, et al. Prevalence and relevant factors on echocardiographic left ventricular hypertrophy among community-based hypertensive patients in Shanghai. Zhonghua Liu Xing Bing Xue Za Zh 2002; 23(3): 182-5.

The authors declare that there are no conflicts of interest present.